Abstract
Nine dimeric bile acid-amino acid conjugates as the mimic of cycle peptide and they have been synthesized in good yield and their structures were well confirmed by 1H NMR, 13C NMR and mass spectra. The ESI-MSn technique was used to probe the conformation of these molecules. The preliminary bioactivity tests showed that some of the title compounds could inhibit the growth of human breast cancer cell MCF-7. The antitumor activity probably derived from the unique sandwich-type amphiphilic conformation.
Keywords: Bile acid, amphiphile, electrospray mass spectrometry, cytotoxic activity
Letters in Organic Chemistry
Title: Design, Synthesis and Antitumor Activity of Dimeric Bile Acid-Amino Acid Conjugates
Volume: 4 Issue: 6
Author(s): Yan Li, Zhen Zhang, Yong Ju and Chang-Qi Zhao
Affiliation:
Keywords: Bile acid, amphiphile, electrospray mass spectrometry, cytotoxic activity
Abstract: Nine dimeric bile acid-amino acid conjugates as the mimic of cycle peptide and they have been synthesized in good yield and their structures were well confirmed by 1H NMR, 13C NMR and mass spectra. The ESI-MSn technique was used to probe the conformation of these molecules. The preliminary bioactivity tests showed that some of the title compounds could inhibit the growth of human breast cancer cell MCF-7. The antitumor activity probably derived from the unique sandwich-type amphiphilic conformation.
Export Options
About this article
Cite this article as:
Yan Li , Zhen Zhang , Yong Ju and Chang-Qi Zhao , Design, Synthesis and Antitumor Activity of Dimeric Bile Acid-Amino Acid Conjugates, Letters in Organic Chemistry 2007; 4 (6) . https://dx.doi.org/10.2174/157017807781467542
DOI https://dx.doi.org/10.2174/157017807781467542 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Hybrid PET Imaging in Neurologic Disease: PET/MRI Rather than PET/CT
Current Medical Imaging Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14)
Mini-Reviews in Medicinal Chemistry Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Meet Our Editorial Board Member:
Current Medicinal Chemistry The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets DNA Repair Pathways and Human Metastatic Malignant Melanoma
Current Molecular Medicine Hypocalcemia Induced by Raloxifene
Current Drug Safety Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design Editorial (Thematic Issue: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives)
Current Pharmaceutical Design The Phage Display Technique: Advantages and Recent Patents
Recent Patents on DNA & Gene Sequences Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Analysis and Validation of Differentially Expressed MicroRNAs with their Target Genes Involved in GLP-1RA Facilitated Osteogenesis
Current Bioinformatics Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Current Pharmaceutical Design Machine Learning-Based Virtual Screening Strategy RevealsSome Natural Compounds as Potential PAK4 Inhibitors in Triple Negative Breast Cancer
Current Proteomics Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Current Cancer Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Lipids as a Target for Drugs Modulating Multidrug Resistance of Cancer Cells
Current Drug Targets